Millersville, MD – J29, Inc. (J29) is proud to announce that it has been awarded a prime contract by the Defense Health Agency (DHA) to support the Health Plan Innovation Services (HPIS) Pharmacy Program. Under this five-year engagement, J29 will serve as the prime contractor leading a valuable integrated team to support DHA’s Pharmacy Operations Division and the TRICARE Pharmacy Program through strategic pharmacy benefit management, claims review, data analytics, policy support, and program oversight services. The award further expands J29’s growing portfolio of federal healthcare programs and reinforces the company’s commitment to improving the efficiency, effectiveness, and integrity of government-funded healthcare services.
“This award represents exactly the kind of work J29 was built to do—bring the right people, experience, and insight together to make complex healthcare programs stronger for the people they serve,” said Tracy Mills, CEO & Founder, J29, Inc.
Under the HPIS Pharmacy contract, J29 and its critical partners will support the analysis and review of claims, utilization, reimbursement, specialty drug management, and pharmacy cost trends, operational analysis, pharmacy benefit management support, and performance monitoring, business intelligence. The team will help DHA advance data-driven decision-making and innovation across the TRICARE Pharmacy Program by analyzing claims, utilization, reimbursement approaches, specialty drug management, pharmacy cost trends, benefit design, and emerging commercial best practices. These efforts will translate complex findings into actionable recommendations that help DHA optimize pharmacy benefit performance, identify opportunities for cost containment, strengthen oversight mechanisms, and ensure continued access to high-quality pharmacy services for TRICARE beneficiaries and the broader Military Health System.
What distinguishes the J29 Team in this role is its unique combination of healthcare operations expertise, claims management capabilities, program management discipline, advanced analytics competences, and practical experience supporting some of the nation’s most complex healthcare programs. Working alongside supporting partnerships, J29 will provide DHA with transparent reporting, auditable work products, actionable insights, and mission-focused recommendations that support both current operations and future modernization initiatives.
J29 has supported a broad range of federal health and human service programs across the Centers for Medicare & Medicaid Services (CMS), Health Resources and Services Administration (HRSA), Centers for Disease Control and Prevention (CDC), Administration for Strategic Preparedness and Response (ASPR), Department of Labor (DOL), Office of Personnel Management (OPM), Department of Homeland Security (DHS), and the DHA. The addition of the HPIS Pharmacy contract further expands J29’s role supporting complex healthcare delivery and program integrity initiatives across the Federal Government.
Note: The U.S. Department of Defense and Defense Health Agency do not endorse private sector vendors. Any statements regarding J29 are made solely by J29 and do not represent the views or positions of the Federal Government.
About J29
J29 is an employee-centered health and human services management consulting firm proudly supporting programs at the commercial, state, and federal levels. Founded in 2017, J29 specializes in supporting missions involving the processing, reviewing, adjudicating, and analysis of healthcare claims, medical records, disputes, audits, cases, and data sets. With a growing operation supporting programs across CMS, CDC, DHA, DOL, HRSA, CDC, USCIS, ASPR, and other government agencies, J29 delivers clinical, compliance, operational, and technology-enabled solutions that improve outcomes for government customers and the populations they serve.
